# AIB Data Centers Inc.: financial statements, quarterly

AIB · NYSE · CIK 2070542 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aib.md) · [Financials](/companies/aib/financials.md) · [Filings](/companies/aib/filings.md) · [Insiders](/companies/aib/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aib/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $k | [4,500](/filings/0001213900-26-056983.md) | [4,745](/filings/0001213900-26-089151.md) | [4,913](/filings/0001213900-26-056983.md) | [2,915](/filings/0001213900-26-089151.md) |
| Cost of revenue | $k | [3,273](/filings/0001213900-26-056983.md) | [4,196](/filings/0001213900-26-089151.md) | [4,343](/filings/0001213900-26-056983.md) | [3,433](/filings/0001213900-26-089151.md) |
| Selling, general and administrative | $k | [637](/filings/0001213900-26-056983.md) | [897](/filings/0001213900-26-089151.md) | [597](/filings/0001213900-26-056983.md) | [2,711](/filings/0001213900-26-089151.md) |
| Operating income | $k | [426](/filings/0001213900-26-056983.md) | [(542)](/filings/0001213900-26-089151.md) | [(277)](/filings/0001213900-26-056983.md) | [(3,580)](/filings/0001213900-26-089151.md) |
| Net income | $k | [489](/filings/0001213900-26-089151.md) | [(542)](/filings/0001213900-26-089151.md) | [(273)](/filings/0001213900-26-089151.md) | [(3,481)](/filings/0001213900-26-089151.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001213900-26-056983.md) | [(0.01)](/filings/0001213900-26-089151.md) | [(0.01)](/filings/0001213900-26-056983.md) | [(0.07)](/filings/0001213900-26-089151.md) |
| Basic EPS | $ per share | [0.01](/filings/0001213900-26-056983.md) | [(0.01)](/filings/0001213900-26-089151.md) | [(0.01)](/filings/0001213900-26-056983.md) | [(0.07)](/filings/0001213900-26-089151.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001213900-26-089151.md) | [1.3](/filings/0001213900-26-056983.md) | [52.8](/filings/0001213900-26-089151.md) |
| Current assets | $m | [3.5](/filings/0001213900-26-089151.md) | [3.7](/filings/0001213900-26-056983.md) | [57.7](/filings/0001213900-26-089151.md) |
| Total assets | $m | [17.3](/filings/0001213900-26-089151.md) | [36.3](/filings/0001213900-26-056983.md) | [90.4](/filings/0001213900-26-089151.md) |
| Current liabilities | $m | [8.7](/filings/0001213900-26-089151.md) | [8.7](/filings/0001213900-26-056983.md) | [7.6](/filings/0001213900-26-089151.md) |
| Total liabilities | $m | [9.4](/filings/0001213900-26-089151.md) | [9.1](/filings/0001213900-26-056983.md) | [7.7](/filings/0001213900-26-089151.md) |
| Shareholders' equity | $m | [7.9](/filings/0001213900-26-089151.md) | [27.2](/filings/0001213900-26-056983.md) | [82.7](/filings/0001213900-26-089151.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [411](/filings/0001213900-26-056983.md) | [(1,400) d](/filings/0001213900-26-089151.md) | [1,275](/filings/0001213900-26-056983.md) | [(5,947) d](/filings/0001213900-26-089151.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.6](/filings/0001213900-26-056983.md) | [37.6](/filings/0001213900-26-089151.md) | [37.6](/filings/0001213900-26-056983.md) | [46.8](/filings/0001213900-26-089151.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 75,979,466 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001213900-26-089151.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.